Get startedLog in
    Picture of Abeona Therapeutics logo

    ABEO — Abeona Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapSucker Stock
    All News

    Brief: Abeona Therapeutics Holds Pre-IND Meeting With FDA For ABO-701 In Prostate Cancer - SEC Filing

    Picture of Abeona Therapeutics logoAbeona Therapeutics
    04/06/2026 12:33
    BRIEF-Abeona Therapeutics Holds Pre-IND Meeting With FDA For ABO-701 In Prostate Cancer - SEC Filing
    June 4 (Reuters) - Abeona Therapeutics Inc ABEO.O:
    • ABEONA THERAPEUTICS - HOLDS PRE-IND MEETING WITH FDA FOR ABO-701 IN PROSTATE CANCER - SEC FILING
    • ABEONA THERAPEUTICS - TARGETS IND SUBMISSION FOR ABO-701 IN 2027 - SEC FILING
    Source text: [ID:n0001493152-26-027197]
    Further company coverage: ABEO.O

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Abeona Therapeutics

    See all news